STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
WASHINGTON — The pharmaceutical and biotech industries are pushing back against two Trump administration proposals that would test plans to lower drug prices in Medicare by aligning them with the prices paid in other rich countries. Their comments preview arguments that th...
🔗 Read more: https://www.statnews.com/2026/02/24/pharma-opposition-medicare-drug-price-pilot-programs-strategy-emerges/?utm_campaign=rss
#News #Policy #Tech #WorldNews #Biotech #Software #Science
Edited
www.statnews.com
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
WASHINGTON — The pharmaceutical and biotech industries are pushing back against two Trump administration proposals that would test plans to lower drug prices in Medicare by aligning them with the prices paid in other rich countries. Their comments preview arguments that they might use in court...
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!